CBD drug shows promise for OCD and tics in tiny study
NCT ID NCT04978428
First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times
Summary
This small study tested whether Epidiolex (a prescription CBD oil) can safely reduce symptoms of obsessive-compulsive disorder, hair-pulling, Tourette syndrome, and hoarding. Four adults took the drug for two weeks. The goal was to see if symptoms improved and if the drug was well-tolerated.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HOARDING DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Chicago
Chicago, Illinois, 60637, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Inside the hoarding brain: can scans reveal why letting go is so hard?
- Can a single ketamine infusion quiet the obsessive mind?
- Can improv comedy help tame OCD?
- A Two-Year watch: can brain scans and surveys predict depression and anxiety in teens?
- Therapy may let kids with OCD ditch meds for good
- Could gut bacteria hold the key to childhood OCD?